Clinical Trial Update: Shortness Of Breath Questionnaire Validation Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a shortness of breath questionnaire for COPD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: WITHDRAWN